Ouvrages publiés en collaboration (1)

  1. 1. Van Houtte, P., Charlier, F., Moretti, L., & Van Gestel, D. (2020). Radiotherapy an Alternative to Surgery. doi:10.5772/intechopen.94486
  2.   Articles dans des revues avec comité de lecture (76)

  3. 1. Bouchart, C., Azurmendi Senar, O., Navez, J., Verset, L., Boisson, A., Hein, M., Stosic, K., Quertinmont, E., Tafciu, V., Zhao, S., Mas, L., D'Haene, N., Van Gestel, D., Moretti, L., Michiels, E., Rooman, I., Detours, V., Bachet, J.-B., Demetter, P., Willard-Gallo, K., Nicolle, R., Arsenijevic, T., & Van Laethem, J.-L. (2026). Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy. British Journal of Cancer. doi:10.1038/s41416-025-03274-0
  4. 2. Mootassim-Billah, S., Van Nuffelen, G., Schoentgen, J., De Bodt, M. M., Slama, H., Le Tensorer, M., & Van Gestel, D. (2025). Airflow Features Obtained From Voluntary Throat Clearing Compared to Voluntary Cough and Induced Reflexive Cough in a Healthy Population. International journal of language and communication disorders.
  5. 3. Mootassim-Billah, S., Schoentgen, J., De Bodt, M. M., Slama, H., Willemse, E., Dragan, T., Roper, N., Le Tensorer, M., Kristanto, P., Paesmans, M., Van Gestel, D., & Van Nuffelen, G. (2025). Acoustic Features of Airway Protective Maneuvers as Biomarkers of Radiation-Associated Dysphagia and Penetration/Aspiration in Head and Neck Cancer Patients. Head and Neck, 47(9), 2464-2485.
  6. 4. Sant’Angelo, D., Descamps, G., Lecomte, V., Stanicki, D., Penninckx, S., Dragan, T., Van Gestel, D., Laurent, S., & Journe, F. (2025). Therapeutic Approaches with Iron Oxide Nanoparticles to Induce Ferroptosis and Overcome Radioresistance in Cancers. Pharmaceuticals, 18(3), 325. doi:10.3390/ph18030325
  7. 5. de Bakker, T., Maes, A., Dragan, T., Martinive, P., Penninckx, S., & Van Gestel, D. (2025). Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer. Cells, 14(1), 18. doi:10.3390/cells14010018
  8. 6. Dragan, T., Soussy, K., Beauvois, S., Lefebvre, Y., Lemort, M., Ozalp, E., Gulyban, A., Burghelea, M., Wardi, C. A., Marin, C., Benkhaled, S., & Van Gestel, D. (2024). Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study. Clinical and Translational Radiation Oncology, 48, 100837. doi:10.1016/j.ctro.2024.100837
  9. 7. Schoenauen, L., Stubbe, F. X., Van Gestel, D., Penninckx, S., & Heuskin, A.-C. (2024). C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect. Clinical and Translational Radiation Oncology, 45, 100712. doi:10.1016/j.ctro.2023.100712
  10. 8. De Caluwe, A., Romano, E., Poortmans, P., Gombos, A., Agostinetto, E., Marta, G. N., Denis, Z., Drisis, S., Vandekerkhove, C., Desmet, A., Philippson, C., Craciun, L., Veys, I., Larsimont, D., Paesmans, M., Van Gestel, D., Salgado, R., Sotiriou, C., Piccart-Gebhart, M., Ignatiadis, M., & Buisseret, L. (2023). First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for ImmunoTherapy of Cancer, 11(12). doi:10.1136/jitc-2023-007279
  11. 9. Mootassim-Billah, S., Van Nuffelen, G., Schoentgen, J., De Bodt, M. M., & Van Gestel, D. (2023). Assessment of radio(chemo)therapy‑related dysphagia in head and neck cancer patients based on cough‑related acoustic features: a prospective phase II national clinical trial (ACCOUGH‑P/A trial). Trials.
  12. 10. Burghelea, M., Bakkali Tahiri, J., Dhont, J., Kyndt, M., Gulyban, A., Szkitsak, J., Bogaert, E., Van Gestel, D., & Reynaert, N. (2023). Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency. Physics and Imaging in Radiation Oncology, 28, 100479. doi:10.1016/j.phro.2023.100479
  13. 11. Van Houtte, P., & Van Gestel, D. (2023). A quality assurance program: a clear necessity in modern oncology care. Precision cancer medicine, 6, 7921. doi:10.21037/pcm-23-14

  14. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>